Method and device for purifying by-product potassium fluoroborate in synthesis of pharmaceutical intermediates
A technology for by-product potassium fluoroborate and a purification method is applied in the field of purification of by-product potassium fluoroborate in the synthesis of pharmaceutical intermediates, and can solve the problem of quenching the catalytic activity of boron trifluoride-acetonitrile complex, secondary pollution and disposal costs Advanced problems, to achieve the effect of rapid and efficient degradation, reduced consumption, and high selectivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031]Under constant stirring, the reaction temperature was controlled at 40 °C, and 1 mol / L sodium carbonate solution was added to the final solution system of the 2000 mL pharmaceutical intermediate reaction (the synthesis reaction of pharmaceutical intermediates using boron trifluoride acetonitrile complex as a catalyst). , adjust the pH to 6.0 to obtain the intermediate crystallization solution, centrifuge to obtain the intermediate wet product, and further refine and process; the centrifugal filtrate mainly contains sodium fluoroborate solution, add 200-300 mL of saturated potassium chloride solution, and keep the temperature at 20 ℃ Next, the potassium fluoroborate granular solid is crystallized under stirring, and the crystallization time is controlled to be no less than 60 minutes, and then centrifuged, and 200 mL of deionized water alternately washes the potassium fluoroborate crystals multiple times to obtain potassium fluoroborate wet solids, which are transferred to ...
Embodiment 2
[0033] Under the condition of constant stirring, control the reaction temperature at 40 ° C, add 1 mol / L sodium carbonate passivator to the 2000 L pharmaceutical intermediate reaction final solution system, adjust the pH to 6.5-7, add 200 L of saturated potassium chloride solution to obtain The intermediate crystal solution is centrifuged to obtain the intermediate wet product, which is further refined and processed; the centrifuge filtrate mainly contains sodium fluoroborate solution, and the potassium fluoroborate crystals are alternately washed with 200L deionized water, and then sent to the fluidized bed oxidation by an automatic screw machine Impurity removal reactor, through enzymatic hydrolysis and oxidation technology, add 10g compound enzyme solution (Ganoderma lucidase laccase: cyanohydrolase: bromoperoxidase = 1:2:1, compound enzyme activity 20000-50000IU), reaction control 20-30°C, reaction time 2h, 2L hydrogen peroxide (added in two stages, the first stage is enzym...
Embodiment 3
[0038] A purification device for by-product potassium fluoroborate in the synthesis of pharmaceutical intermediates, comprising a primary treatment system and a secondary purification system, the discharge port of the primary treatment system is connected with the feed port of the secondary purification system, and the primary treatment system is connected with the feed port of the secondary purification system. The primary treatment system is used for crystallization and primary centrifugal treatment, and the secondary refining system is used for enzymatic hydrolysis, oxidation and secondary centrifugal treatment. The primary treatment system includes a crystallization tank and a primary centrifuge.
[0039] like image 3 As shown, the secondary refining system includes a potassium fluoroborate silo 1, the outlet of the potassium fluoroborate silo is connected with the feed port of the fluidized bed impurity removal reactor 2, and the fluidized bed impurity removal The air i...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


